Subscribe to RSS
DOI: 10.1055/s-0038-1637230
ENDOSCOPIC PAPILLECTOMY: LONG TERM RESULTS IN 110 CONSECUTIVE PATIENTS
Publication History
Publication Date:
27 March 2018 (online)
Aims:
Ampullary adenomas represents 5% of the neoplasia of the gastrointestinal tract with a premalignant nature. Aim of this study is to evaluate the results and the long-term follow-up of endoscopic papillectomy (EP) of adenoma of the ampulla of Vater.
Methods:
Consecutive patients undergoing EP between May 2000 and October 2017.
The following data were recorded: size of the ampullary lesion, pre- and post-EP histology, complications, local recurrence rate and survival. Endoscopic follow-up was scheduled after 1, 3, 6 and 12 months for the first year, and then yearly for the following 5 years.
Results:
EP was performed in 110 consecutive patients (61 F, mean age 59.2). 77.3% en-bloc resection, 22.7% piecemeal. 28 patients (25.4%) had familiar adenomatous polyposis (FAP).
Biliary sphincterotomy with or without insertion of a plastic stent was performed after EP in 77 patient (70%).
Histopatological findings are summarized in table 1.
Low Grade Dysplasia, n (%) |
27 (24.5) |
High Grade Dysplasia, n (%) |
36 (32.7) |
High Grade Dysplasia + focal Adenocarcinoma, n (%) |
17 (15.4) |
Intramucosal Adenocarcinoma, n (%) |
24 (22.0) |
Neuroendocrine tumor, n (%) |
6 (5.4) |
Delayed bleeding was reported in 19 patients (17.3%) treated endoscopically, except in 1 case.
Retroperitoneal perforations occurred in 3/110 (2.7%) cases and were successfully treated by surgical (n = 2) or percutaneous (n = 1) drainage.
Regular follow-up was available in 94/110 patients (85.4%), mean 31.6 months (range 1 – 108).
Residual and recurrent adenomas were diagnosed in 28 (29.8%) and 19 (20.2%) cases, respectively and were successfully retreated endoscopically except in 4 cases treated by surgery.
Nine patients (8.2%) with adenocarcinoma on final histology, were referred to surgery.
Conclusions:
EP is effective with favorable long-term outcomes avoiding invasive surgical procedures. The high incidence of residual/recurrent adenoma is balanced by the successful endoscopic re-treatment.